ArticleBiochemistry and biophysics reports2026
Iron nanoparticles - biodistribution in the chicken embryo model.
Article in Biochemistry and biophysics reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Magnetic nanoparticles (MNPs) show promise in many biomedical applications, including magnetic resonance imaging (MRI). Iron carbide compounds are good theragnostic contrast agents. Being nanosized might enable passage through a placenta, posing risks to embryonic development. This study investigates the biodistribution of intravenously injected carbon coated iron nanoparticles (ICNP) in chicken embryos. Materials and methods: Carbon coated iron nanoparticles (300 μg or 600 μg) were injected into a blood vessel on the chorioallantoic membrane (CAM) of chicken embryos (stages 23 to 26) according to Hamburger-Hamilton (H&H). 24 h after ICNP injection, embryos were formalin-fixed and imaged with T2-weighted MRI. Eighteen embryos (three per H&H stage 24-26 and dosage) were further analysed for ICNP deposits via MRI, histology, scanning electron microscopy (SEM) and X-ray spectroscopy (EDX). Results: Strong signal void artefacts were observed when treated with 600 μg and more pronounced with advancing stages. Deposits were prominent around the vascular system, however all developing organs showed ICNP deposits. Histological and SEM microscopy confirmed inter- and intracellular ICNP uptake in the developing brain. Iron was quantitatively verified in spots of histological sections by EDX. The overall tissue architecture remained intact. Conclusion: The ICNPs are distributed into most embryo organs and cells without causing damage to the tissue and cells. Their potential to affect embryogenesis warrants further long-term investigation. If proven safe, ICNPs may be used as effective theragnostic agents in MRI as well as for personalized medicine because they can be functionalized with specific proteins or antibodies tailored at patient-specific targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.